Psychosocial Factors and Aging: Resting/Reflexive Cardiovascular Control
Psychosocial Factors and Aging: Resting/Reflexive Cardiovascular Control
批准号:
8532602
负责人:
Richard P SLOAN
金额:
$21.99万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-15 至 2015-03-31
关键词:
AffectiveAgeAgingAtherosclerosisAutonomic nervous systemBaroreflexBehavioralBiological MarkersBlood PressureCardiacCardiovascular systemClinicClinicalCommunitiesConsensusDataData CollectionDevelopmentDiagnosisEntropyFrequenciesHealthHeart RateHeart failureHourHypertensionInflammatoryLinkMeasurementMeasuresMethodsMorbidity - disease rateMyocardial InfarctionNoiseOrganParticipantPatientsPeriodicityPhysiologicalPhysiologyPositioning AttributePsychosocial FactorRecoveryResearchRestRiskSamplingSeriesTestingTherapeutic InterventionTimeTransplant RecipientsVariantadverse outcomeautonomic reflexbasecardiovascular risk factorclinically significantcommunity health studycontextual factorsfollow-upheart rate variabilityindexinginsightmiddle agemortalitynovelpressureprognosticprospectivepsychologicpsychosocialpublic health relevanceresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): For decades, we have known that lower heart rate (HR) is associated with reduced morbidity and mortality. But HR is not stable - it is inherently "noisy," oscillating around the mean. Beginning in the 1980s, the clinical and physiological significance of these oscillations, now known as Heart Rate Variability (HRV), has been recognized. HRV predicts adverse outcomes following myocardial infarction or diagnosis of heart failure, progression of atherosclerosis in CAD patients, and the development of CAD in healthy community samples. Thus, measurement "noise" in HR is now recognized as a valuable index of cardiovascular health. Today, blood pressure (BP) is in a similar position as HR was 40 years ago. While the clinical significance of mean blood pressure (BP) has been accepted for decades, within-subject BP varies considerably across multiple time scales. Once dismissed as noise, BP variability (BPV) now also is thought to contain valuable information. Measured repeatedly over weeks or even years, the standard deviation (SD) of clinic-to-clinic BP predicted the development of hypertension and mortality after 12-14 years follow-up. On a 24-hour scale, the SD of BP measured every 30 min was associated with cardiovascular mortality after 8.5 years follow-up and with greater target organ damage. At a still shorter time scale, BP varies on a beat-to-beat basis. Consensus in the field is that the ultimate prognostic value of BPV may require analysis of these beat-to-beat BP oscillations. However, because measurement of these more rapid oscillations has been technically demanding, associations of beat-to-beat BPV with clinical or with psychosocial variables linked to health have not been established. Technological advances have made beat-to-beat BPV increasingly available and exploration of its relationship to cardiovascular health and contextual sociodemographic and psychosocial cardiovascular risk factors has the potential to yield important clinical and physiological insights. Measuring beat-to-beat BP along with RR intervals also allows for computation of baroreflex sensitivity (BRS), the relationship of reflexive changes in RR interval to changes in BP. While BPV may represent a tonic autonomic index, BRS is an index of autonomic reflexes that predicts adverse outcomes after MI and in heart failure. However, to our knowledge, community studies of BPV and BRS do not exist. We propose to analyze the beat-to-beat BP data already collected but not analyzed from participants at rest and in response to psychological and orthostatic challenge from the wave 2 of data collection in the Midlife in the US (MIDUS II) study. Our aims in this R21 are to examine relationships between resting and reactive BPV and BRS and psychosocial and biomarker data across the age spectrum and in an exploratory prospective analysis, to test whether greater BPV and lower BRS are associated with greater mortality.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders
-
批准号:10457914
-
项目类别:
-
资助金额:$72.74万
-
财政年份:2018
-
负责人:Richard P SLOAN
-
依托单位:
Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders
-
批准号:9975668
-
项目类别:
-
资助金额:$76.41万
-
财政年份:2018
-
负责人:Richard P SLOAN
-
依托单位:
Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders
-
批准号:9933182
-
项目类别:
-
资助金额:$34.78万
-
财政年份:2018
-
负责人:Richard P SLOAN
-
依托单位:
Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders
-
批准号:9766169
-
项目类别:
-
资助金额:$78.83万
-
财政年份:2018
-
负责人:Richard P SLOAN
-
依托单位:
Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders
-
批准号:10187474
-
项目类别:
-
资助金额:$74.94万
-
财政年份:2018
-
负责人:Richard P SLOAN
-
依托单位:
Exercise, aging, and cognition: Effect and mechanisms
-
批准号:8526315
-
项目类别:
-
资助金额:$93.42万
-
财政年份:2010
-
负责人:Richard P SLOAN
-
依托单位:
Exercise, Age-Related Memory Decline, and Hippocampal Function.
-
批准号:8325547
-
项目类别:
-
资助金额:$59.97万
-
财政年份:2010
-
负责人:Richard P SLOAN
-
依托单位:
Exercise, aging, and cognition: Effect and mechanisms
-
批准号:8723714
-
项目类别:
-
资助金额:$96.52万
-
财政年份:2010
-
负责人:Richard P SLOAN
-
依托单位:
Exercise, aging, and cognition: Effect and mechanisms
-
批准号:7986691
-
项目类别:
-
资助金额:$101.7万
-
财政年份:2010
-
负责人:Richard P SLOAN
-
依托单位:
Exercise, Age-Related Memory Decline, and Hippocampal Function.
-
批准号:7986086
-
项目类别:
-
资助金额:$57.69万
-
财政年份:2010
-
负责人:Richard P SLOAN
-
依托单位:
Instrumentation and Laboratory Procedures
-
批准号:8147568
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2010
-
负责人:Richard P SLOAN
-
依托单位:
Exercise, aging, and cognition: Effect and mechanisms
-
批准号:8318672
-
项目类别:
-
资助金额:$98.03万
-
财政年份:2010
-
负责人:Richard P SLOAN
-
依托单位:
Exercise, Age-Related Memory Decline, and Hippocampal Function.
-
批准号:8534009
-
项目类别:
-
资助金额:$56.67万
-
财政年份:2010
-
负责人:Richard P SLOAN
-
依托单位:
Exercise, Age-Related Memory Decline, and Hippocampal Function.
-
批准号:8733503
-
项目类别:
-
资助金额:$58.47万
-
财政年份:2010
-
负责人:Richard P SLOAN
-
依托单位:
Exercise, Age-Related Memory Decline, and Hippocampal Function.
-
批准号:8141236
-
项目类别:
-
资助金额:$59.97万
-
财政年份:2010
-
负责人:Richard P SLOAN
-
依托单位:
Exercise, aging, and cognition: Effect and mechanisms
-
批准号:8141233
-
项目类别:
-
资助金额:$98.79万
-
财政年份:2010
-
负责人:Richard P SLOAN
-
依托单位:
Exercise and Inflammation: Autonomic, Affective & Cellular Mechanisms
-
批准号:7737279
-
项目类别:
-
资助金额:$74.45万
-
财政年份:2009
-
负责人:Richard P SLOAN
-
依托单位:
Exercise and Inflammation: Autonomic, Affective & Cellular Mechanisms
-
批准号:8102127
-
项目类别:
-
资助金额:$74.22万
-
财政年份:2009
-
负责人:Richard P SLOAN
-
依托单位:
Exercise and Inflammation: Autonomic, Affective & Cellular Mechanisms
-
批准号:7923101
-
项目类别:
-
资助金额:$74.91万
-
财政年份:2009
-
负责人:Richard P SLOAN
-
依托单位:
Exercise and Inflammation: Autonomic, Affective & Cellular Mechanisms
-
批准号:8286890
-
项目类别:
-
资助金额:$75.2万
-
财政年份:2009
-
负责人:Richard P SLOAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: